Monitoring and Assessing the Safety of Disease-Modifying Antirheumatic Drugs: A West Midlands Experience

Author： Jobanputra P.   Maggs F.   Homer D.   Bevan J.  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.15, 2002-01, pp. : 1099-1105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical and Economic Review of Disease-Modifying Antirheumatic Drugs

By Gabriel S.E.  

PharmacoEconomics, Vol. 19, Iss. 7, 2001-07 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Disease-Modifying Antirheumatic Drugs: Using Their Clinical Pharmacological Effects As a Guide to Their Selection

By Jackson C.G.  

Drugs, Vol. 56, Iss. 3, 1998-09 ,pp. : 337-344

Adis International

Access to resources Recommend Favorite

Disease-Modifying Antirheumatic Drugs in Pregnancy: Current Status and Implications for the Future

By Vroom Fokaline  

Drug Safety, Vol. 29, Iss. 10, 2006-01 ,pp. : 845-863

Adis International

Access to resources Recommend Favorite

Clinically Important Drug Interactions with Disease-Modifying Antirheumatic Drugs

By Haagsma C.J.  

Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. : 281-289

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine

By Umićević Mirkov Maša   Coenen Marieke JH  

Pharmacogenomics, Vol. 14, Iss. 4, 2013-03 ,pp. : 425-444

Future Medicine

Access to resources Recommend Favorite